| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Clozapine | FAERS: 13 | OFFSIDES US FAERS | |
| 2 | Valsartan | FAERS: 11 | US FAERS | |
| 3 | Tacrolimus | FAERS: 8 | US FAERS | |
| 4 | Ibuprofen | FAERS: 4 | US FAERS | |
| 5 | Oxcarbazepine | FAERS: 4 | US FAERS | |
| 6 | Telmisartan | FAERS: 4 | US FAERS | |
| 7 | Aspirin | FAERS: 3 | US FAERS | |
| 8 | 4-hydroxybutyric acid | FAERS: 2 | US FAERS | |
| 9 | Gabapentin | FAERS: 2 | US FAERS | |
| 10 | Letrozole | FAERS: 2 | US FAERS | |
| 11 | Naproxen | FAERS: 2 | US FAERS | |
| 12 | Sevikar | FAERS: 2 | US FAERS | |
| 13 | Sulfasalazine | FAERS: 2 | US FAERS | |
| 14 | 1-(((alpha-isobutanoyloxyethoxy)carbonyl)aminomethyl)-1-cyclohexaneacetic acid | FAERS: 1 | US FAERS | |
| 15 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 1 | US FAERS | |
| 16 | Amoxicillin | FAERS: 1 | US FAERS | |
| 17 | Atomoxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 18 | Cephalexin | FAERS: 1 | US FAERS | |
| 19 | Lenalidomide | FAERS: 1 | US FAERS | |
| 20 | Mesalamine | FAERS: 1 | US FAERS | |
| 21 | Mycophenolic Acid | FAERS: 1 | US FAERS | |
| 22 | Nexium 24hr | FAERS: 1 | US FAERS | |
| 23 | Norgestrel | FAERS: 1 | US FAERS | |
| 24 | Risperidone | FAERS: 1 | US FAERS | |
| 25 | Terbinafine | FAERS: 1 | US FAERS | |
| 26 | Thyroxine | FAERS: 1 | US FAERS | |
| 27 | ambrisentan | FAERS: 1 | US FAERS | |
| 28 | anagrelide | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120326
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.